Immunitybio Inc (IBRX)

Income Before Tax

-$230.39M

Quarterly · Period ending: · USD

IBRX logo

IBRX Income Before Tax

Latest reported-$230.39M
IBRX Quarterly Pre-Tax Income (-$84.58M → -$230.39M)
High-resolution chart · PNG

IBRX income before tax history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Immunitybio Inc Income Before Tax — Quarterly (USD)
Period endingIncome Before Tax (USD)
-230,390,000
-632,791,000
-62,093,000
-67,309,000
-92,305,000
-129,900,000
-59,179,000
-85,752,000
-134,584,000
-134,130,000
-233,454,000
-95,642,000
-138,213,000
-116,583,000
-108,292,000
-111,161,000
-94,835,000
-102,998,000
-91,552,000
-88,429,000
-89,383,000
-80,475,000
-32,133,000
-67,870,000
-51,972,000
-37,409,000
22,259,000
-15,581,000
-16,680,000
-17,921,000
-17,468,000
-23,763,000
-27,855,000
-27,643,000
-24,659,000
-24,068,000
-23,576,000
-24,613,000
-24,387,000
-31,949,000
-34,225,000
-30,793,000
-77,123,000
-42,649,000
-84,581,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.